Oncologist. CMO @myAccessHope. Adjunct Professor @DukeMedSchool. Photographer.
Joined December 2007
- Tweets 5,043
- Following 612
- Followers 6,213
- Likes 3,523
657 Photos and videos
13 Nov 2024
I’m thrilled to join AccessHope as chief medical officer!
At AccessHope, our mission is clear: optimize patient outcomes & make cancer care more accessible and equitable for all. I’m deeply honored to join this incredible team, which keeps patients at the heart of every decision
13 Nov 2024
We’re thrilled to announce that renowned oncologist @yzafar, M.D., MHS has joined as our new chief medical officer and digital health veteran @peterbridges has joined as our chief strategy and growth officer. Debra Morris, our COO/CFO has also been promoted to president.
myaccesshope.org/press-relea…
7
3
32
5,464
Yousuf Zafar, MD MHS retweeted
14 Jun 2023
Proud of this work and it’s legacy in highlighting the need to identify and address financial burdens faced by patients with cancer - and my enduring friendship with the fantastic @yzafar
Reflections on the Financial Toxicity of Cancer: 10 Years Later academic.oup.com/oncolo/arti…
2
15
41
5,806
12 Jan 2023
So much fun chatting with @pbcancerdoc about how @ThymeCares is addressing key challenges in cancer care delivery
13
923
For #ASCODailyNews, @yzafar breaks down how technology & data can lower #cancercare costs, reduce acute care utilization, & streamline clinician workflow, allowing the real work of precision care delivery to begin: fal.cn/3sJHs #healthtech #precisionmedicine
5
8
4 Oct 2022
LOVE this: "Looking for an actually concise explanation of a half-century’s worth of research and arguments about health care spending in the U.S.?" Well, here it is in one ppt.
Thanks, @bobjherman @statnews statnews.com/2022/10/03/get-…
cc: @DusetzinaS @StephWheelerUNC
1
5
39
Yousuf Zafar, MD MHS retweeted
6 Jul 2022
Scientists NEED to become better communicators.
Proud of this manuscript highlighting HOW to present your research to diverse audiences, WHY it matters, and some Do's & Don'ts.
With: Drs @aaronecarroll @DusetzinaS @yzafar & Ms. @sangerkatz in @JNCI_Now academic.oup.com/jncimono/ar…
3
35
134
7 Jun 2022
Deciding between adjuvant therapy yes/no for stage II #coloncancer?
Check out @gabe_a_brooks great summary. I would only add this: patient preference plays a role, of course #ASCO22
7 Jun 2022
My preliminary takeaways re: DYNAMIC:
In stage 2 colon cancer, only three biomarkers are ultimately useful for selecting adjuvant therapy candidates after R0 resection. They are:
T4
dMMR
ctDNA positivity (provisional)
1/4 #ASCO22
1
8
Yousuf Zafar, MD MHS retweeted
6 Jun 2022
40% of Black patients say no one mentioned clinical trials to them. >90% say they want information on trials.
This is shameful. We, as a community, need to do SO MUCH BETTER.
@tigerlilycares #bcsm #clinicaltrials #ASCO22 @OncoAlert
7
66
235
Yousuf Zafar, MD MHS retweeted
6 Jun 2022
In her PARADIGM plenary discussion @ChiaraCrem1 (who is OWNING #ASCO22 podiums by the way) observed a ~3.5 month *loss* of median OS with bev first in 1st line L-sided ras/braf wt, MSS colon cancer
1
4
13
6 Jun 2022
You know it’s big news when my mom in Ohio called me about this study. Congratulations to @AndreaCercek and team for a huge result for the benefit of our patients #ASCO22
5 Jun 2022
Very proud of our study published in @NEJM. 100% clinical complete response with dostarlimab alone in mismatch repair-deficient locally advanced #RectalCancer. No radiation or surgery! @ASCO #ASCO22 @MSKCancerCenter nejm.org/doi/full/10.1056/NE…
1
8
4 Jun 2022
Tonight, I’m seeing @HAIMtheband in downtown Chicago! Tomorrow, looking forward to seeing old friends and new data at #ASCO22
12
Yousuf Zafar, MD MHS retweeted
3 Jun 2022
So proud of Dr @NarjustDumaMD’s well earned place on this @TheCancerLetter timeline on the evolution of @ASCO annual meetings. Her #asco18 work on #genderEquity was essential at exposing what we can and should improve. cancerletter.com/in-the-arch…
1
4
18
3 Jun 2022
I cannot say enough about how proud I am of @fumikochino!! Then add @familyreach into the mix, and I’m swooning. #ASCO22
3 Jun 2022
👏 Huge congrats to @fumikochino for winning the Excellence in Equity Award from @ASCO! We're honored to be in the fight against #financialtoxicity alongside changemakers like you. #ASCO22 #healthequity
dailynews.ascopubs.org/do/10…
18
3 Jun 2022
Fun @TheCancerLetter article on memories from 57yrs of @ASCO (& thx for kind words, @fumikochino!)
#MyFirstASCO: I was a resident standing by a lonely HSR poster, watching in awe as Jane Weeks presented, wondering if I’d ever get to do that! #ASCO22
cancerletter.com/cancer-hist…
13
3 Jun 2022
US spends more on cancer than any other country--by far. But cancer mortality? Just below median
We're missing something (emphasis on costly Rx & not on prevention/Dx?). Let's keep this in mind at #ASCO22
Great work by @cpgYALE @YaleCOPPER jamanetwork.com/journals/jam…
6
24
Yousuf Zafar, MD MHS retweeted
19 May 2022
It should go without saying, but it evidently can’t be said enough: good science communication matters.
We are failing over and over and over again.
8
21
233
Yousuf Zafar, MD MHS retweeted
4 May 2022
Your Money or Your Life — The High Cost of #Cancer Drugs under Medicare Part D.
nejm.org/doi/10.1056/NEJMp22…
@NEJM @DusetzinaS @fumikochino @yzafar
#FinancialToxicity #PallOnc #HealthCare
2
8
25
18 Apr 2022
Getting to the source of inequity in healthcare means getting to the source of inequity in society.
This is a good start.
fiercehealthcare.com/provide…
6